Article

Utilization of Thromboelastogram and Inflammatory Markers in the Management of…

Case Reports in Critical Care · 2020 · Angela Smolarz, author Paul McCarthy, author Aaron Shmookler, author Vinay Badhwar, author Awori J. Hayanga, author Ankit Sakhuja, author Silvia Natoli, Academic Editor

Key facts

Title Utilization of Thromboelastogram and Inflammatory Markers in the Management of Hypercoagulable State in Patients with COVID-19 Requiring ECMO Support
First author Angela Smolarz, author Paul McCarthy, author Aaron Shmookler, author Vinay Badhwar, author Awori J. Hayanga, author Ankit Sakhuja, author Silvia Natoli, Academic Editor
Journal Case Reports in Critical Care
Published Sep 26, 2020
DOI 10.1155/2021/8824531
Devices mentioned K002177, K041502, K140893, K160502, K183160, K243858, K953681, K993678
Product codes mentioned GGN, GKT, JOZ, JPA, LKN, OUG

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature